These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 23183941)

  • 41. Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials.
    Bangalore S; Fayyad R; Hovingh GK; Laskey R; Vogt L; DeMicco DA; Waters DD;
    Am J Cardiol; 2014 Jun; 113(12):2018-20. PubMed ID: 24793673
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Red yeast rice and coenzyme Q10 as safe alternatives to surmount atorvastatin-induced myopathy in hyperlipidemic rats.
    Abdelbaset M; Safar MM; Mahmoud SS; Negm SA; Agha AM
    Can J Physiol Pharmacol; 2014 Jun; 92(6):481-9. PubMed ID: 24896301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-dose atorvastatin on the pharmacodynamic effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) study.
    Leoncini M; Toso A; Maioli M; Angiolillo DJ; Giusti B; Marcucci R; Abbate R; Bellandi F
    JACC Cardiovasc Interv; 2013 Feb; 6(2):169-79. PubMed ID: 23428009
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tachyphylaxis and statin drugs.
    Stein JH; McBride PE
    Am J Cardiol; 2001 Mar; 87(5):674. PubMed ID: 11245286
    [No Abstract]   [Full Text] [Related]  

  • 45. A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle.
    Laaksonen R; Katajamaa M; Päivä H; Sysi-Aho M; Saarinen L; Junni P; Lütjohann D; Smet J; Van Coster R; Seppänen-Laakso T; Lehtimäki T; Soini J; Oresic M
    PLoS One; 2006 Dec; 1(1):e97. PubMed ID: 17183729
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia.
    Koh KK; Quon MJ; Han SH; Chung WJ; Ahn JY; Seo YH; Choi IS; Shin EK
    J Am Coll Cardiol; 2005 May; 45(10):1649-53. PubMed ID: 15893182
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The atorvastatin during ischemic stroke study: a pilot randomized controlled trial.
    Muscari A; Puddu GM; Santoro N; Serafini C; Cenni A; Rossi V; Zoli M
    Clin Neuropharmacol; 2011; 34(4):141-7. PubMed ID: 21677574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atorvastatin for the treatment of plaque-type psoriasis.
    Faghihi T; Radfar M; Mehrabian Z; Ehsani AH; Rezaei Hemami M
    Pharmacotherapy; 2011 Nov; 31(11):1045-50. PubMed ID: 22026392
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of high-dose atorvastatin on renal function in subjects with stroke or transient ischemic attack in the SPARCL trial.
    Amarenco P; Callahan A; Campese VM; Goldstein LB; Hennerici MG; Messig M; Sillesen H; Welch KM; Wilson DJ; Zivin JA
    Stroke; 2014 Oct; 45(10):2974-82. PubMed ID: 25147328
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study.
    Waubant E; Pelletier D; Mass M; Cohen JA; Kita M; Cross A; Bar-Or A; Vollmer T; Racke M; Stüve O; Schwid S; Goodman A; Kachuck N; Preiningerova J; Weinstock-Guttman B; Calabresi PA; Miller A; Mokhtarani M; Iklé D; Murphy S; Kopetskie H; Ding L; Rosenberg E; Spencer C; Zamvil SS; ;
    Neurology; 2012 Apr; 78(15):1171-8. PubMed ID: 22459680
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease.
    Mohler ER; Hiatt WR; Creager MA
    Circulation; 2003 Sep; 108(12):1481-6. PubMed ID: 12952839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can a high reloading dose of atorvastatin prior to percutaneous coronary intervention reduce periprocedural myocardial infarction?
    Nafasi L; Rahmani R; Shafiee A; Salari A; Abdollahi A; Meysamie A
    Curr Med Res Opin; 2014 Mar; 30(3):381-6. PubMed ID: 23952289
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic infections can decrease the threshold of statin-induced muscle injury.
    Mahboobi SK; Shohat EZ; Jellinek SP; Rose M
    South Med J; 2006 Apr; 99(4):403-4. PubMed ID: 16634254
    [No Abstract]   [Full Text] [Related]  

  • 54. Influence of Baseline Psychological Health on Muscle Pain During Atorvastatin Treatment.
    Zaleski AL; Taylor BA; Pescatello LS; Dornelas EA; White CM; Thompson PD
    J Cardiovasc Nurs; 2017; 32(6):544-550. PubMed ID: 27870723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Persisting weakness after withdrawal of a statin.
    Mygland Å; Ljøstad U; Krossnes BK
    BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24713712
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy.
    Taylor BA; Lorson L; White CM; Thompson PD
    Atherosclerosis; 2015 Feb; 238(2):329-35. PubMed ID: 25545331
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia.
    Gagné C; Gaudet D; Bruckert E;
    Circulation; 2002 May; 105(21):2469-75. PubMed ID: 12034651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia.
    Draeger A; Monastyrskaya K; Mohaupt M; Hoppeler H; Savolainen H; Allemann C; Babiychuk EB
    J Pathol; 2006 Sep; 210(1):94-102. PubMed ID: 16799920
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does coenzyme-Q have a protective effect against atorvastatin induced myopathy? A histopathological and immunohistochemical study in albino rats.
    Khalil MS; Khamis N; Al-Drees A; Abdulghani HM
    Histol Histopathol; 2015 Mar; 30(3):383-90. PubMed ID: 25366571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Side effects of the HMG-CoA reductase inhibitors (statins). Lupus erythematosus induced by Atorvastatin therapy].
    Hydzik P; Szpak D
    Przegl Lek; 2011; 68(8):495-8. PubMed ID: 22010448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.